NASDAQ:UPXI - Nasdaq - US39959A2050 - Common Stock - Currency: USD
5.61
+0.34 (+6.45%)
The current stock price of UPXI is 5.61 USD. In the past month the price increased by 34.53%. In the past year, price increased by 43.55%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
UL | UNILEVER PLC-SPONSORED ADR | 23.3 | 149.09B | ||
KVUE | KENVUE INC | 19.49 | 41.16B | ||
EL | ESTEE LAUDER COMPANIES-CL A | 43.98 | 32.43B | ||
ELF | ELF BEAUTY INC | 32.56 | 6.26B | ||
BRBR | BELLRING BRANDS INC | 17.95 | 4.95B | ||
COTY | COTY INC-CL A | 20.42 | 4.27B | ||
IPAR | INTERPARFUMS INC | 23.57 | 3.88B | ||
ODD | ODDITY TECH LTD-CL A | 27.22 | 3.24B | ||
EPC | EDGEWELL PERSONAL CARE CO | 8.42 | 1.02B | ||
HLF | HERBALIFE LTD | 4.49 | 942.11M | ||
OLPX | OLAPLEX HOLDINGS INC | 15.67 | 938.95M | ||
YSG | YATSEN HOLDING LTD-ADR | N/A | 897.87M |
Upexi, Inc. engages in the development, manufacturing, and distribution of consumer products through direct-to-consumer network, wholesale partnerships, and major third-party platforms like Amazon. The company is headquartered in Tampa, Florida and currently employs 64 full-time employees. The company went IPO on 2021-06-24. The firm focuses on direct-to-consumer and Amazon brands. The Company’s brands include LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, Gumi Labs, and Upexi Distribution. LuckyTail products consist of its flagship nail grinder and healthy all-natural pet supplements. Gumi Labs manufactures gummies and other products supporting its health and wellness products, including those products manufactured with hemp ingredients. Upexi Distribution manages the warehousing and logistic needs of the Company and provides storage, consolidation, assembly, Amazon preparation, distribution and fulfilment services to its brands and its manufacturing operation.
UPEXI INC
3030 Rocky Point Drive, Suite 420
Tampa FLORIDA US
Employees: 95
Phone: 17013535425
The current stock price of UPXI is 5.61 USD. The price increased by 6.45% in the last trading session.
The exchange symbol of UPEXI INC is UPXI and it is listed on the Nasdaq exchange.
UPXI stock is listed on the Nasdaq exchange.
UPEXI INC (UPXI) has a market capitalization of 282.58M USD. This makes UPXI a Micro Cap stock.
UPEXI INC (UPXI) currently has 95 employees.
UPEXI INC (UPXI) has a support level at 4.85 and a resistance level at 6. Check the full technical report for a detailed analysis of UPXI support and resistance levels.
The Revenue of UPEXI INC (UPXI) is expected to grow by 8.09% in the next year. Check the estimates tab for more information on the UPXI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
UPXI does not pay a dividend.
UPEXI INC (UPXI) will report earnings on 2025-09-22, after the market close.
UPEXI INC (UPXI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-20.73).
The outstanding short interest for UPEXI INC (UPXI) is 3.06% of its float. Check the ownership tab for more information on the UPXI short interest.
ChartMill assigns a technical rating of 1 / 10 to UPXI. When comparing the yearly performance of all stocks, UPXI is a bad performer in the overall market: 65.39% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to UPXI. UPXI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months UPXI reported a non-GAAP Earnings per Share(EPS) of -20.73. The EPS decreased by -311.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -149.36% | ||
ROE | -1215.98% | ||
Debt/Equity | 0.31 |
ChartMill assigns a Buy % Consensus number of 43% to UPXI. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 30.61% and a revenue growth 8.09% for UPXI